Acute fetal distress;La souffrance fœtale aiguë

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 30, Issue 5, 2001, Pages 393-432

  Boog, G ^a   Dreyfus, M ^a  

^a Hopital Mere Enfant CHU de Nantes   (France)

Author keywords

Acute fetal distress; Fetal heart rate; Fetal pulse oximetry; Fetal scalp sampling; Neonatal encephalopathy

Indexed keywords

LACTIC ACID;

APGAR SCORE; ASPHYXIA; BLOOD GAS; BRAIN DISEASE; DECELERATION; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; FETUS DISTRESS; FETUS HEART RATE; FETUS MONITORING; HEART RATE VARIABILITY; HUMAN; HYPOXIA; LABOR; METABOLIC ACIDOSIS; PH; PULSE OXIMETRY; REVIEW; SCALP; UMBILICAL ARTERY; ACUTE DISEASE; CLASSIFICATION; ELECTROCARDIOGRAPHY; FEMALE; FETUS DEATH; FETUS HEART; FORCEPS DELIVERY; HOSPITALIZATION; INSTRUMENTATION; METABOLISM; METHODOLOGY; NEWBORN; OXIMETRY; PREDICTION AND FORECASTING; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; REFERENCE VALUE; RESUSCITATION; RISK FACTOR; STANDARD; TIME;

ACUTE DISEASE; APGAR SCORE; ELECTROCARDIOGRAPHY; EXTRACTION, OBSTETRICAL; FEMALE; FETAL DEATH; FETAL DISTRESS; FETAL HEART; FETAL MONITORING; HUMANS; INFANT, NEWBORN; OXIMETRY; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY OUTCOME; PROGNOSIS; REFERENCE VALUES; RESUSCITATION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 0035209517     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (324)

1. A template for defining a causal relation between acute intrapartum events and cerebral palsy: International consensus statement
2. Souffrance fœtale aiguë
3. Classifying meconium-stained liquor: Is it feasible?
4. Determinants of meconium-stained amniotic fluid in term pregnancies
5. Risk of meconium-stained amniotic fluid in different ethnic groups
6. Meconium stained amniotic fluid: Antenatal, intrapartum and neonatal attributes
7. Meconium stained amniotic fluid in very low risk pregnancies at term gestation
8. Meconium: A marker for peripartum infection
9. Meconium-stained amniotic fluid. Current controversies
10. Obstetric and perinatal outcome of pregnancies with term labour and meconium-stained amniotic fluid
11. Meconium stained amniotic fluid in preterm delivery is an independent risk factor for perinatal complications
12. Meconium: A 1990s perspective on an old obstetric hazard
13. Meconium-stained amniotic fluid: Increased risk for adverse neonatal outcome
14. Maternal and perinatal outcome of patients with preterm labor and meconium-stained amniotic fluid
15. Meconium stained amniotic fluid is associated with maternal infectious morbidity in pre term delivery
16. Obstetric risk factors for periventricular leukomalacia among preterm infants
17. Meconium-stained amniotic fluid and risk for cerebral palsy in preterm infants
18. The placenta in meconium staining: Lesions and early neonatal outcome
19. An assessment of the use of meconium alone as an indication for fetal blood sampling
20. Meconium in the amniotic fluid and fetal acid-base status
21. Meconium staining of the liquor in a low-risk population
22. Amniotic fluid meconium: A fetal environmental hazard
23. Acid-base significance of meconium discovered prior to labor
24. Markers of acute and chronic asphyxia in infants with meconium-stained amniotic fluid
25. Cord blood erythropoietin in relation to different markers of fetal hypoxia
26. Influence of postdatism and meconium on fetal erythropoietin
27. Meconium aspiration syndrome: Intrapartum and neonatal attributes
28. Risk factors for meconium aspiration syndrome
29. Meconium-stained amniotic fluid and respiratory complications: Impact of selective tracheal suction
30. Variables associated with meconium aspiration syndrome in labors with thick meconium
31. Prediction of the severity of meconium aspiration syndrome
32. Risk factors for meconium aspiration syndrome in infants born through thick meconium
33. Fetal oxygen saturation measured by pulse oximetry during labour with clear or meconium-stained amniotic fluid
34. Intrapartum fetal heart rate monitoring
35. Uncertain value of electronic fetal monitoring in predicting cerebral palsy
36. Cerebral palsy among children born during the Dublin randomised trial of intrapartum monitoring
37. Intrapartum electronic fetal heart rate monitoring versus intermittent auscultation: A meta-analysis
38. Intrapartum electronic fetal monitoring: Data for clinical decisions
39. Intrauterine resuscitation of the compromised fetus
40. Electronic fetal heart rate monitoring: Early neonatal outcomes associated with normal rate, fetal stress, and fetal distress
41. Interrelationships among abnormal cardiotocograms in labor, meconium staining of the amniotic fluid, arterial cord blood pH, and Apgar scores
42. Observations on heart rate and pH in the human fetus during labor
43. The significance of the changes in the continuous fetal heart rate in the first stage of labour
44. Correlation of fetal heart rate-uterine contraction patterns with fetal scalp blood pH
45. The development of fetal acidosis in the presence of an abnormal fetal heart rate tracing. I. The average for gestational age fetus
46. Intrapartum fetal surveillance. Is it worthwhile?
47. Predictive value of electronic fetal monitoring for intrapartum fetal asphyxia with metabolic acidosis
48. Periodic spectral components of fetal heart rate variability reflect the changes in cord arterial base deficit values: A preliminary report
49. The paradox of electronic fetal monitoring: More data may not enable us to predict or prevent infant neurologic morbidity
50. Neurodevelopmental outcome and electronic fetal heart rate monitoring in a neonatal intensive care population
51. Perinatal observations in forty-eight neurologically impaired term infants
52. Fetal heart rate observations in the brain-damaged infant
53. Uterine rupture after previous cesarean delivery: Maternal and fetal consequences
54. Umbilical cord prolapse. Is the time from diagnosis to delivery critical?
55. Intrapartum fetal heart rate variability and subsequent neonatal cerebral edema
56. Electronic fetal heart monitoring, auscultation, and neonatal outcome
57. The intrapartum CTG prior to neonatal encephalopathy at term: A case-control study
58. Antecedents of cerebral palsy. I. Univariate analysis of risks
59. Antecedents of cerebral palsy. Multivariate analysis of risk
60. Normal fetal heart rate pattern in the brain-damaged infant: A failure of intrapartum fetal monitoring?
61. Severe fetal brain injury without evident intrapartum asphyxia or trauma
62. How much of neonatal encephalopathy is due to birth asphyxia?
63. Clustering of perinatal markers of birth asphyxia and outcome at age five years
64. Fetal heart rate patterns during labor: Neurologic and cognitive development at six to nine years of age
65. Electronic fetal monitoring: What's reassuring?
66. Intrapartum fetal heart rate monitoring. II - Multifactorial analysis of intrapartum fetal heart rate tracings
67. Diagnostic de la souffrance fœtale au cours du travail à l'aide du score cardio-tocographique de Hammacher et de la mesure du pH fœtal
68. Inconsistencies in classification by experts of cardiotocograms and subsequent clinical decision
69. The scalp stimulation test - A clinical alternative to fetal scalp blood sampling
70. Intrapartum assessment of fetal well-being: A comparison of scalp stimulation with scalp blood pH sampling
71. Fetal heart rate response to vibratory acoustic stimulation predicts fetal pH in labor
72. Reactive fetal heart rate response to vibroacoustic stimulation in fetuses with low scalp blood pH
73. Is intrapartum vibratory acoustic stimulation a valid alternative to fetal scalp pH determination?
74. Vibroacoustic and scalp stimulation
75. Alterations in the fetal electrocardiogram as a sign of fetal asphyxia-experimental data with a clinical implementation
76. The relationship between circulating catecholamines and ST waveform in the fetal lamb electrocardiogram during hypoxia
77. The potential impact of PR interval analysis of the fetal electrocardiogram (FECG) on intrapartum fetal monitoring
78. Fetal acidæmia, the cardiotocograph, and the T/QRS ratio of the fetal ECG in labour
79. Can fetal electrocardiography improve the prediction of intrapartum fetal acidosis?
80. Clinical assessment of fetal electrocardiogram monitoring in labour
81. Comparison of the T/QRS ratio of the fetal electrocardiogram and the fetal heart rate during labour and the relation of these variables to condition at delivery
82. The fetal electrocardiogram: Relationship with acidemia at delivery
83. European Community multi-Center Trial "Fetal ECG Analysis During Labor": ST plus CTG analysis
84. Improving intrapartum surveillance: An individualised T/QRS ratio?
85. A comparative study of the fetal electrocardiogram recorded by the STAN and Nottingham systems
86. Plymouth randomized trial of electrocardiogram only versus ST waveform plus cardiotocogram for intrapartum monitoring in 2400 cases
87. Randomised trial of cardiotocography alone or with ST waveform analysis for intrapartum monitoring
88. Fetal electrocardiogram plus heart rate recording for fetal monitoring during labour
89. Changes in the PR interval-fetal heart rate relationship of the electrocardiogram during fetal compromise in chronically instrumented sheep
90. Improved intrapartum surveillance with PR interval analysis of the fetal electrocardiogram: A randomized trial showing a reduction in the fetal blood sampling
91. Calcul automatique des surfaces de ralentissement du rythme cardiaque fœtal
92. Computer assessment of the intrapartum cardiotocogram. I - Methods of data reduction and diagnosic procedure
93. Computerized fetal heart rate analysis in labor
94. Fetal heart rate patterns in term labor vary with sex, gestational age, epidural analgesia, and fetal weight
95. The effect of uterine contractions on intrapartum fetal heart rate analysed by a computerized system
96. Applications pratiques de l'analyse informatisée du rythme cardiaque fœtal par le système Sonicaid Oxford 8002 au cours de la grossesse et de l'accouchement
97. Analysis of umbilical artery flow parameters during fetal variable decelerations using computerized Doppler waveforms
98. Doppler blood flow velocity waveforms of the umbilical artery during variable decelerations in labor
99. Umbilical artery blood flow velocity waveforms during variable deceleration of the fetal heart rate
100. Changes in umbilical arterial and venous blood flow velocity waveforms during late decelerations of the fetal heart rate
101. Fetal umbilical blood flow velocity waveforms using Doppler ultrasonography in patients with late decelerations
102. Fetal cerebral blood flow velocity during labor
103. Continuous subcutaneous pH measurement in human fetuses. Correlations with scalp and umbilical blood pH
104. Continuous acid-base assessment of the human fetus during labour by tissue pH and transcutaneous carbon dioxide monitoring
105. Continuous intrapartum measurement of tissue pH of the human fetus using newly developed techniques
106. Intrapartum fetal pulse oximetry. I: Principles and technical issues
107. Intrapartum fetal pulse oximetry. Part 2: Clinical application
108. Fetal monitoring by pulse oximetry and cardiotocography
109. Continuous intrapartum pH, pO2, pCO2, and SpO2 monitoring
110. Multicenter study on the clinical value of fetal pulse oximetry. II. Compared predictive values of pulse oximetry and fetal blood analysis
111. Preliminary experience with intrapartum fetal pulse oximetry in humans
112. Intrapartum fetal pulse oximetry: Fetal oxygen saturation trends during labor and relation to delivery outcome
113. Fetal oxygen saturation during maternal bearing down efforts in the second stage of labor
114. Fetal pulse oximetry. A methodological study
115. Evaluation of fetal heart rate patterns during the second phase of labor through fetal oximetry
116. Fetal pulse oximetry: Correlation between changes in oxygen saturation and neonatal outcome. Preliminary report on 39 cases
117. Fetal pulse oximetry during labor of 62 patients
118. Prediction of umbilical artery base excess by intrapartum fetal oxygen saturation monitoring
119. Do fetal pulse oximetry readings at delivery correlate with cord blood oxygenation and acidæmia?
120. Fetal oxygen saturation monitoring in labour: An analysis of 118 cases
121. Evaluation méthodologique. Etude multicentrique
122. Multicenter study on the clinical value of fetal pulse oximetry. I. Methodologic evaluation
123. Fetal pulse oximetry and non-reassuring heart rate
124. Continuous monitoring of fetal oxygen saturation by pulse oximetry
125. Comparing fetal pulse oximetry with scalp pH
126. Predictive agreement between the fetal arterial oxygen saturation and fetal scalp pH: Results of the German multicenter study
127. The relationship between oxygen saturation and pH in umbilical blood: Implications for intrapartum fetal oxygen saturation monitoring
128. The prediction of fetal acidosis by means of intrapartum fetal pulse oximetry
129. The relevance of intrapartum fetal pulse oximetry in the presence of fetal cardiac arrhythmia
130. Intrapartum fetal pulse oximetry in the presence of fetal cardiac arrhythmia
131. Intrapartum fetal surveillance of congenital heart block with pulse oximetry
132. Reflection pulse oximetry in fetal tachyarrhythmia
133. Surveillance du travail par l'oxymétrie de pouls fœtal dans un cas de bloc auriculo-ventriculaire fœtal
134. Intrapartum fetal pulse oximetry: Past, present, and future
135. Fetal pulse oximetry
136. Clinical usefulness of pulse oximetry in the fetus with nonreassuring heart rate pattern?
137. The efficacy of intrapartum fetal surveillance when fetal pulse oximetry is added to cardiotocography
138. A multicenter controlled trial of fetal pulse oximetry in the intrapartum management of nonreassuring fetal heart rate patterns
139. Trans-abdominal monitoring of fetal arterial blood oxygenation using pulse oximetry
140. Assessment of fetal scalp oxygen saturation determination in the sheep by transmission pulse oximetry
141. Relationship of fetal oxygen consumption and acid-base balance to fetal hematocrit
142. Scalp blood gas analysis
143. Maternal-fetal acid-base physiology
144. Lactaplasmie maternelle et fœtale au cours de l'accouchement. II. Accouchements pathologiques
145. The effect of sampling technique on measurement of fetal blood pH and gases-An in vitro system
146. Place de la determination de l'équilibre acido-basique
147. L'équilibre acido-basique du foetus pendant le travail
148. The reliability of pH-values in fetal blood samples. A study of the second stage
149. Fetal scalp blood pH sampling: Its value in an active obstetric unit
150. Is the risk of perinatal transmission of human immunodeficiency virus increased by the intrapartum use of spiral electrodes or fetal scalp pH sampling
151. Lack of agreement on normal values for fetal scalp blood
152. Fetal scalp blood analysis
153. Acid-base evaluation of umbilical cord blood: Relation to delivery mode and Apgar scores
154. Are there two biological parts in the second stage of labor?
155. The effect of labor on the normal values of umbilical blood acid-base status
156. Time: An important variable in normal delivery
157. Fetal heart rate variability: An approach to automated assessment
158. The prediction of intrapartum fetal metabolic acidosis by fetal heart rate monitoring
159. Correlation of fetal heart rate patterns and fetal pH with neonatal outcome
160. Intrapartum fetal heart rate: Correlation with scalp pH in the preterm fetus
161. Clinical fetal monitoring. VII. The evaluation and significance of intrapartum baseline FHR variability
162. Prediction of acid-base values from intrapartum fetal heart rate data and their correlation with scalp and funic values
163. Computer assessment of the intra-partum cardiotocogram. II. The value of computer assessment compared with visual assessment
164. The influence of scalp sampling on the cesarean section rate for fetal distress
165. Congenital complete heart block and successful vaginal delivery
166. Monitoring the fetus during labour
167. Fetal distress and the condition of newborn infants
168. Fetal distress and the condition of the newborn using cardiotocography and fetal blood analysis during labour
169. Is fetal blood sampling and pH estimation helpful or harmful?
170. The practical implications of cord blood acid-base studies
171. Reliability of fetal blood sampling. Maternal-fetal relationships
172. The Apgar score: Is it enough?
173. Clinical implications of perinatal depression
174. Maternal-fetal pH difference and fetal scalp pH as predictors of neonatal outcome
175. Vibroacoustic and scalp stimulation
176. Elimination of fetal scalp blood sampling on a large clinical service
177. Routine measurements of umbilical artery lactate levels in the prediction of perinatal outcome
178. Lactate compared with pH analysis at fetal scalp blood sampling: Prospective randomised study
179. Role of lactate measurements during labor
180. A new method for rapid measurement of lactate in fetal and neonatal blood
181. Predictive value of fetal scalp blood lactate concentration and pH as markers of neurologic disability
182. Lactate in scalp and cord blood from fetuses with ominous fetal heart rate patterns
183. Intrapartum risk factors for newborn encephalopathy: The Western Australian case-control study
184. Renal venous thrombosis: An unusual cause of fetal distress
185. Fetal acoustic stimulation in early labor and pathological fetal acidemia: A preliminary report
186. Fetal recoil during labor to evaluate fetal well-being when heart rate monitoring is not informative
187. Umbilical artery Doppler velocimetry as a labor admission test
188. Fetal biophysical profile
189. Intrauterine resuscitation of the compromised fetus?
190. Intrapartum fetal assessment. A review
191. Management of fetal distress
192. Intrapartum fetal pulse oximetry: The effects of maternal hyperoxia on fetal arterial oxygen saturation
193. The effect on fetal arteriolar oxygen saturation resulting from giving oxygen to the mother measured by pulse oximetry
194. Maternal oxygen administration for fetal distress
195. Amnioinfusion for meconium-stained liquor
196. L'amnioinfusion
197. Intrapartum amnioinfusion for meconium-stained fluid: Meta-analysis of prospective clinical trials
198. Amnioinfusion for meconium-stained liquor in labour
199. L'amnioinfusion pendant le travail
200. Amnioinfusion pendant le travail: Expérience et revue de la littérature
201. Amnioinfusion for umbilical cord compression in labour
202. Operative versus conservative management for "fetal distress" in labour
203. Piracetam for fetal distress in labour
204. Results obtained with piracetam in foetal distress during labour
205. Tocolysis for preventing fetal distress in second stage of labour
206. Decision to delivery intervals for assisted vaginal vertex delivery
207. Intravenous nitroglycerin to relieve intrapartum fetal distress related to uterine hyperactivity: A prospective observational study
208. Tocolytics for suspected intrapartum fetal distress
209. Intrapartum tocolysis has no effect on fetal lactate concentration
210. Intrapartum fetal distress and magnesium sulfate
211. Correction de l'acidose fœtale par l'injection intra-amniotique de bicarbonate de sodium
212. Fetal acidemia associated with regional anesthesia for elective cesarean delivery
213. Higher rate of fetal acidemia after regional anesthesia for elective cesarean delivery
214. Lateral tilt for cæsarean section
215. Lack of benefits of left tilt in emergent cesarean sections: A randomized study of cardiotocography, cord acid-base status and other parameters of the mother and the fetus
216. What factors modify the condition of the newborn infant in emergency cesarean section?
217. Cesarean section for suspected fetal distress. Does the decision-incision time make a difference?
218. Evaluating the thirty minute interval in emergency cesarean sections
219. Delivery room resuscitation of the newborn
220. Acid-base equilibrium in umbilical cord blood and time of cord clamping
221. Collecting and analysing cord blood gases
222. Umbilical cord blood gas analysis
223. Determination of fetal acidemia at birth from a remote umbilical arterial blood gas analysis
224. A practical approach to umbilical artery pH and blood gas determinations
225. Postpartum determination of umbilical artery blood gases: Effect of time and temperature
226. The reliability of the result of the umbilical cord pH
227. Umbilical cord pH and pCO2: Effect of interval from delivery to determination
228. Reliability of individual umbilical artery measurements
229. Umbilical cord blood gases: The effect of smoking on delayed sampling from the placenta
230. "Normal" umbilical arterial and venous acid-base gas values
231. Umbilical arterial and venous acid-base and blood gas values and the effect of chorioamnionitis on those values in a cohort of preterm infants
232. Intrapartum asphyxia in pregnancies complicated by intraamniotic infection
233. The effect of fetal sepsis on umbilical cord blood gases
234. Correlation of neonatal acid-base status with Apgar scores and fetal heart rate tracings
235. Second stage fetal heart rate abnormalities and neonatal acidosis?
236. Second-stage heart rate abnormalities and type of neonatal acidemia
237. Do Apgar scores indicate asphyxia?
238. Evaluation de l'asphyxie néonatale par micro-dosage rapide des lactates au sang du cordon
239. Umbilical cord blood gas analysis at delivery: A time for quality data
240. The etiology of fetal acidosis as determined by umbilical cord acid-base studies
241. Long term outcome after umbilical artery acidæmia at term birth: Influence of gender and duration of fetal heart rate abnormalities
242. Outcome of resuscitated apparently stillborn infants: A ten year review
243. Perinatal risk factors related to neurologic outcomes of term newborns with asphyxia at birth: A prospective study
244. The continuing value of the Apgar score for the assessment of newborn infants
245. Outcome after successful resuscitation of babies born with Apgar scores of 0 at both 1 and 5 minutes
246. Apgar scores as predictors of chronic neurologic disability
247. Diagnosis of birth asphyxia on the basis of fetal pH, Apgar score, and newborn cerebral dysfunction
248. Correlations between obstetric clinical events and umbilical cord blood acid-base and blood gas values
249. Neonatal complications at term as related to the degree of umbilical artery acidemia
250. Asphyxial complications in the term newborn with severe umbilical acidemia
251. Follow-up of children born with an umbilical arterial blood pH < 7
252. Association between umbilical blood gas parameters and neonatal morbidity and death in neonates with pathologic fetal acidemia
253. Neonatal complications in newborns with an umbilical artery pH < 7.00
254. Threshold of metabolic acidosis associated with newborn complications
255. The relationship of asphyxia in the mature fetus to long-term neurologic function
256. Newborn complications after intrapartum asphyxia with metabolic acidosis in the term fetus
257. Clinical implications of perinatal depression
258. Umbilical arteriovenous PO2 and PCO2 differences and neonatal morbidity in term infants with severe acidosis
259. Prospective validation of a scoring system for predicting neonatal morbidity after acute perinatal asphyxia
260. Encéphalopathie anoxique du nouveau-né à terme et hypothermie cérébrale
261. Mechanisms of perinatal cerebral injury in fetus and newborn
262. Predictors of neonatal encephalopathy in full-term infants
263. Cerebral palsy and neonatal encephalopathy
264. Antecedents of neonatal encephalopathy with fetal acidæmia at term
265. Intrapartum fetal asphyxial brain injury with absent multiorgan system dysfunction
266. Neonatal encephalopathy following fetal distress
267. Does asphyxia cause cerebral palsy?
268. EEG and long-term outcome of term infants with neonatal hypoxic-ischemic encephalopathy
269. Amplitude integrated EEG 3 and 6 hours after birth in full term neonates with hypoxic-ischæmic encephalopathy
270. Hypoxic-ischemic encephalopathy in the fullterm newborn. Contribution of electroencephalography and MRI or computed tomography to its prognostic evaluation. A propos of 26 cases
271. Multimodality evoked potentials as a prognostic tool in term asphyxiated newborns
272. Somatosensory-evoked potentials in term neonates with postasphyxial encephalopathy
273. Visual-evoked potentials in neonates following asphyxia
274. Postnatal changes in serum immunoreactive erythropoietin in relation to hypoxia before and after birth
275. Nucleated red blood cells as a marker of acidemia in term neonates
276. Nucleated red blood cell count at birth as an index of perinatal brain damage
277. The relationship between nucleated red blood cell counts and early-onset neonatal seizures
278. Neonatal nucleated red blood cell counts in growth-restricted fetuses: Relationship to arterial and venous Doppler studies
279. Measurement of the urinary lactate: Creatinine ratio for the early identification of newborn infants at risk for hypoxic-ischemic encephalopathy
280. Comparison between creatine kinase brain isoenzyme (CKBB) activity and Sarnat score for prediction of adverse outcome following perinatal asphyxia
281. Intrapartum fetal hypoxia and biochemical markers: A review
282. Early cranial ultrasound changes as predictors of outcome during first year of life in term infants with perinatal asphyxia
283. MR patterns of hypoxic-ischemic brain damage after prenatal, perinatal or postnatal asphyxia
284. Neonatal hypoxic-ischemic encephalopathy: Detection with diffusion-weighted MR imaging
285. Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy
286. Correlation of basal ganglia magnetic resonance spectroscopy with Apgar score in perinatal asphyxia
287. MR imaging of perinatal brain damage: Comparison of clinical outcome with initial and follow-up findings
288. Rolandic type cerebral palsy in children as a pattern of hypoxic-ischemic injury in the full-term neonate
289. Head growth in infants with hypoxic-ischemic encephalopathy: Correlation with neonatal magnetic resonance imaging
290. The continuing fall in incidence of hypoxic-ischæmic encephalopathy in term infants
291. Preserving brain function during neonatal asphyxia
292. The use of hypothermia: A role in the treatment of neonatal asphyxia?
293. Selective head Cooling in newborn infants after perinatal asphyxia: A safety study
294. Newborn assessment and long-term adverse outcome: A systematic review
295. Factors associated with motor and cognitive defects in children after intrapartum fetal hypoxia
296. Acid-base status at birth and neurodevelopmental outcome at four and one-half years
297. Apgar score, meconium and acidæmia at birth in relation to neonatal neurological morbidity in term infants
298. Hypoxic-ischemic encephalopathy in term neonates: Perinatal factors and outcome
299. Potentially asphyxiating conditions and spastic cerebral palsy in infants of normal birth weight
300. The incidence of cerebral palsy
301. A changing pattern of cerebral palsy. Declining trend for incidence of cerebral palsy in the 20-year period 1970-1989
302. The changing pattern of cerebral palsy in Avon
303. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-1990
304. Routine umbilical cord blood gas determinations?
305. Umbilical cord blood arterial gas analysis at delivery
306. Is the determination of umbilical cord arterial blood gases necessary in all deliveries? Analysis in a high-risk population
307. Intrapartum hypoxic-ischemic cerebral injury and subsequent cerebral palsy: Medicolegal issues
308. The neurologically impaired child and alleged mal-practice at birth
309. Intrapartum asphyxia: A rare cause of cerebral palsy
310. Destructive brain lesions of presumed fetal onset: Antepartum causes of cerebral palsy
311. Perinatal antecedents of cerebral palsy
312. Cerebral palsy and mental retardation in relation to indicators of perinatal asphyxia. An epidemiologic overview
313. Antenatal antecedents of moderate and severe cerebral palsy
314. Assessing the contribution of birth asphyxia to cerebral palsy in term singletons
315. Can neurological injury be timed?
316. Determining the time before birth when ischemia and hypoxia initiated cerebral palsy
317. Cerebral palsy: MR findings in 40 patients
318. Magnetic resonance imaging findings in cerebral palsy
319. Clinicopathologic implications of placental pathology
320. Neuropathologic documentation of prenatal brain damage
321. Case-control study of intrapartum care, cerebral palsy, and perinatal death
322. Is intrapartum fetal brain injury in the term fetus preventable?
323. The obstetric mangement of fetal distress and its association with cerebral palsy
324. Birth asphyxia and the intrapartum cardiotocograph